Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (70)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jenkins, J. M.
Right arrow Articles by Masson, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenkins, J. M.
Right arrow Articles by Masson, G. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 6, No. 7, pp. 918-921, 1991
© 1991 European Society of Human Reproduction and Embryology


other

Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization

J. M. Jenkins1, D. W. Davies, H. Devonport, F. W. Anthony, S. C. Gadd, R. H. Watson and G. M. Masson

University Department of Obstetrics and Gynaecology, Princess Anne & BUPA Chalybeate Hospitals Southampton, Hants SO9 4HA, UK

Correspondence: 1To whom correspondence should be addressed

This study identifies a group of 87 patients, who demonstrated a ‘poor’ response to a standard buserelin/human menopausal gonadotrophin (HMG) regime. The subsequent outcome in 61 of these ‘poor’ responders when treated with a higher dose of HMG to achieve a satisfactory response was compared with 250 patients, who showed a ‘good’ response to the standard regime. ‘Poor’ responders were significantly older than ‘good’ responders (P < 0.001), but no significant difference was demonstrated in the indication for in-vitro fertilization (IVF). Even on higher doses of HMG, ‘poor’ responders took longer for their follicles to achieve maturity than the ‘good’ responders (P < 0.01). ‘Poor’ responders produced 8.9 oocytes per oocyte collection compared to 11.8 in the ‘good’ responders (P < 0.01). The fertilization rate was significantly lower in the ‘poor’ responders compared to the ‘good’ responders (P < 0.01). Although there was no significant difference in morphometric grading between ‘poor’ responder embryos and ‘good’ responder embryos, the rate of cell division was significantly slower in embryos of the ‘poor’ responders than the ‘good’ responders (P < 0.01). The pregnancy rate per oocyte retrieval was 9% in the ‘poor’ responders compared to 29% in the ‘good’ responders (P < 0.01). The implantation rate in the ‘poor’ responders was 4.4% compared to 16.1% in the ‘good’ responders (P < 0.001).

Key words: poor response/pituitary down-regulation/buserelin/in-vitro fertilization


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
E.M. Kolibianakis, C.A. Venetis, K. Diedrich, B.C. Tarlatzis, and G. Griesinger
Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis
Hum. Reprod. Update, November 1, 2009; 15(6): 613 - 622.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. G. Lainas, I. A. Sfontouris, E. G. Papanikolaou, J. Z. Zorzovilis, G. K. Petsas, G. T. Lainas, and E. M. Kolibianakis
Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial
Hum. Reprod., June 1, 2008; 23(6): 1355 - 1358.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. McIlveen, J.D. Skull, and W.L. Ledger
Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population
Hum. Reprod., March 1, 2007; 22(3): 778 - 785.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Kan, E. H. Y. Ng, W. S. B. Yeung, and P. C. Ho
Perifollicular vascularity in poor ovarian responders during IVF
Hum. Reprod., June 1, 2006; 21(6): 1539 - 1544.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. May-Panloup, M.F. Chretien, C. Jacques, C. Vasseur, Y. Malthiery, and P. Reynier
Low oocyte mitochondrial DNA content in ovarian insufficiency
Hum. Reprod., March 1, 2005; 20(3): 593 - 597.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Kailasam, S.D. Keay, P. Wilson, W.C.L. Ford, and J.M. Jenkins
Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome
Hum. Reprod., July 1, 2004; 19(7): 1544 - 1547.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.L. Luborsky, P. Thiruppathi, B. Rivnay, R. Roussev, C. Coulam, and E. Radwanska
Evidence for different aetiologies of low estradiol response to FSH: age-related accelerated luteinization of follicles or presence of ovarian autoantibodies
Hum. Reprod., October 1, 2002; 17(10): 2641 - 2649.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Nikolaou, S. Lavery, C. Turner, R. Margara, and G. Trew
Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure?
Hum. Reprod., April 1, 2002; 17(4): 1106 - 1111.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S.D. Keay, E.A. Lenton, I.D. Cooke, M.G.R. Hull, and J.M. Jenkins
Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme
Hum. Reprod., September 1, 2001; 16(9): 1861 - 1865.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
P. Thiruppathi, S. Shatavi, J.A. Dias, E. Radwanska, and J.L. Luborsky
Gonadotrophin receptor expression on human granulosa cells of low and normal responders to FSH
Mol. Hum. Reprod., August 1, 2001; 7(8): 697 - 704.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
E. Alexopoulos, J. Shahid, H.Z. Ongley, and M.C. Richardson
Luteinized human granulosa cells are associated with endogenous basement membrane-like components in culture
Mol. Hum. Reprod., April 1, 2000; 6(4): 324 - 330.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. De Placido, C. Alviggi, A. Mollo, I. Strina, M.T. Varricchio, and M. Molis
Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone
Hum. Reprod., January 1, 2000; 15(1): 17 - 20.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Battaglia, M. Salvatori, N. Maxia, F. Petraglia, F. Facchinetti, and A. Volpe
Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients
Hum. Reprod., July 1, 1999; 14(7): 1690 - 1697.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K.E. Ratcliffe, F.W. Anthony, M.C. Richardson, and R.W. Stones
Morphology and functional characteristics of human ovarian microvascular endothelium
Hum. Reprod., June 1, 1999; 14(6): 1549 - 1554.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. Lashen, W. Ledger, A. Lopez-Bernal, and D. Barlow
Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?
Hum. Reprod., April 1, 1999; 14(4): 964 - 969.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.